Schedule 13G ownership disclosure

ANIKA THERAPEUTICS INC

Security class unavailable · CUSIP: 035255108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,561,112
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-007359
Form type
SC 13G/A
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
Apr 05, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub